BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 36113)

  • 1. [Hemodynamic effects of bunitrolol].
    Dabizzi RP; Padeletti L; Bechi P
    Boll Soc Ital Cardiol; 1977; 22(2):139-42. PubMed ID: 36113
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodynamic evaluation of pindolol].
    Biffani G; Santini M
    Minerva Cardioangiol; 1976 Sep; 24(9):613-8. PubMed ID: 1012501
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemodynamic evaluation of the action of calcium antagonists].
    Vincenzi M; Allegri P; Barbieri E; Cappelletti F; Carrozza A; De Lio U; Maiolino P; Morlino T; Ometto R
    Boll Soc Ital Cardiol; 1978; (1 Suppl):79-97. PubMed ID: 757682
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemodynamic effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155) at rest and during exercise with special respect to the pulmonary circulation.
    Koch G
    Arzneimittelforschung; 1971 Jan; 21(1):57-61. PubMed ID: 5108382
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemodynamic effects of intravenous administration of dipyridamole].
    De Ponti C; Bardi U
    Cuore Circ; 1970 Oct; 54(5):247-58. PubMed ID: 5503047
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of the hemodynamic effects in man of 2 beta-blockaders: propranolol and practolol].
    Ambrosioni E; Bracchetti D; Russo F; Catizone L; Perri G; Magnani B
    Boll Soc Ital Cardiol; 1972; 17(2):91-101. PubMed ID: 4403643
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of regitine haemodynamics of pulmonary circulation in pulmonary hypertension in man.
    Horzela T; Dubiel JP; Dubiel JS; Pyzik Z; Szczeklik J
    Acta Physiol Pol; 1974 May; 25(3):241-9. PubMed ID: 4842545
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of the new adrenergic beta receptor blockader Kö 1366 (Bunitrolol) on blood circulation].
    Klempt HW; Bender F
    Arzneimittelforschung; 1973 Aug; 23(8):1064-70. PubMed ID: 4148873
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum).
    Török E; Istvánffy M; Halmágyi M; Wagner M; Csukás M
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):200-7. PubMed ID: 6104634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trimethoquinol by intravenous administration. I. Hemodynamic effects].
    Fumagalli G; Mazzola C; Cavallaro GF; Ghiringhelli G
    Clin Ter; 1976 Feb; 76(3):235-52. PubMed ID: 963963
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemodynamic effects of hypertonic sorbitol solutions in anesthesia conditions].
    Schulte am Esch J; Fromm G
    Anasth Intensivther Notfallmed; 1982 Dec; 17(6):336-40. PubMed ID: 7158740
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term hemodynamic effects of bunitrolol at rest and during exercise in essential hypertension.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1979; 1(1):77-83. PubMed ID: 94384
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemodynamic effects of methoxamine in patients with left-to-right shunts.
    Abrahamsen AM; Grendahl H; Müller C
    Acta Med Scand; 1972 Apr; 191(4):283-6. PubMed ID: 5032670
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acute hemodynamic effects of betaxolol in uncomplicated arterial hypertension in young persons].
    Carré AG; Bertrand ME; Libersa CC; Demerville JC; Lekieffre JP
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():171-5. PubMed ID: 6810822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic effects of etomidate].
    Safran D; Pelouze G; Roujas F
    Ann Anesthesiol Fr; 1978; 19(3):214-8. PubMed ID: 28041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the hemodynamic effects of intravenous Trinitrine. Applications to the vasodilator treatment of heart failure, myocardial infarct, and mitral insufficiency].
    Baligadoo S; Ingrand JC; Derrida JP; Savier CH; Chiche P
    Coeur Med Interne; 1978; 17(2):231-42. PubMed ID: 95918
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemodynamic actions of molsidomin in coronary artery disease. Effects on regional myocardial blood flow, segmental ventricular wall motion, ejection phase parameters, ventricular volumes, systemic and pulmonary artery pressures and cardiac output (author's transl)].
    Fleck E; Dirschinger J; Rudolph W
    Herz; 1979 Jun; 4(3):285-92. PubMed ID: 457027
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemodynamic effects of a cardioselective beta-adrenergic inhibitor (ICI 50172) in coronary insufficiency. Preliminary results].
    Rousseau M; Vandenput F; Brasseur L
    Acta Cardiol; 1972; ():Suppl 15:239-54. PubMed ID: 4404471
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemodynamic effects of a cardioselective beta-adrenergic inhibitor (ICI 50172) in coronary insufficiency. Preliminary results].
    Rosseau M; Vandenput F; Brasseur L
    Acta Cardiol; 1972; ():Suppl 15: 239-. PubMed ID: 4147615
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemodynamic changes following blockade of the beta-receptors in healthy persons and in patients with coronary heart disease. Comparison between Trasicor and Inderal].
    Bürgin D
    Schweiz Med Wochenschr; 1968 Jun; 98(25):940-5. PubMed ID: 5699197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.